Harry Destecroix MBE

Harry Destecroix is a visionary deep tech entrepreneur who successfully translated academic research into commercial success. He co-founded Ziylo, a University of Bristol spin-out, developing a synthetic molecule for diabetes treatment, leading to its acquisition by Novo Nordisk for up to $800M. This experience fueled his passion to build a supportive ecosystem for other deep tech startups. co+4

He is the founder of the Science Creates ecosystem, which aims to nurture deep tech companies from ideation to growth. This ecosystem includes specialized lab incubators, a venture capital arm (SCVC) that he co-founded and manages, and an outreach charity (Science Creates Outreach). His work has significantly contributed to establishing Bristol as a prominent deep tech hub in the UK. co+4

Recognized for his contributions to science and entrepreneurship, Harry Destecroix was awarded an MBE in the King's 2025 New Year Honours List. He also received the 2023 RSC Chemistry World Entrepreneur of the Year award and the Barclays’ Icon of the Year entrepreneurship award in 2021, highlighting his leadership and impact in the scientific and business communities. ac+3

Despite facing challenges with ADHD and dyslexia, Harry views these as strengths, enabling him to possess boundless energy, switch between tasks effectively, and visualize complex interconnections. He emphasizes the importance of diverse teams, attributing much of his success to collaborative efforts. rsc